What is a common starting point for insulin therapy in a patient with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Insulin Therapy in Diabetes

For patients with type 2 diabetes, the recommended starting dose of basal insulin is 0.2 units/kg or up to 10 units once daily, while for type 1 diabetes, the typical starting dose is 0.5 units/kg/day with approximately one-third as basal insulin and the remainder as prandial insulin. 1, 2

Type 2 Diabetes Insulin Initiation

When to Start Insulin

  • Consider initiating insulin when A1C ≥9% despite oral medications 2
  • Insulin therapy should be initiated immediately when blood glucose is ≥300-350 mg/dL (16.7-19.4 mmol/L) or A1C ≥10-12%, especially if symptomatic 2
  • Insulin is indicated when patients present with significant hyperglycemia causing ketosis or unintentional weight loss 2

Initial Insulin Regimen for Type 2 Diabetes

  • Start with basal insulin at 0.2 units/kg or 10 units once daily 1, 2
  • Basal insulin is usually prescribed with metformin and possibly one additional non-insulin agent 2
  • Titrate the dose by 2 units twice weekly until fasting blood glucose target is reached 3
  • Common basal insulins include glargine, detemir, or degludec, administered at the same time each day 4, 5

Dose Adjustment Algorithm

  • Start with 10 units or 0.2 units/kg once daily 1
  • Adjust dose based on fasting blood glucose readings 2
  • Increase by 2 units every 3-4 days if fasting glucose remains above target 6
  • Target fasting glucose: 100-130 mg/dL (or as individually determined) 2

Type 1 Diabetes Insulin Initiation

Initial Insulin Regimen

  • Total daily insulin requirement: 0.5 units/kg/day for metabolically stable patients 2
  • Distribute as approximately 50% basal and 50% prandial insulin 2
  • Most patients should be treated with multiple daily injections (MDI) of both prandial and basal insulin 2
  • Rapid-acting insulin analogs should be used to reduce hypoglycemia risk 2

Dosing Specifics

  • Basal insulin: Start with 0.2-0.3 units/kg/day 2
  • Prandial insulin: Typically 0.3-0.5 units/kg/day divided before meals 2
  • Higher weight-based starting doses may be needed for patients with diabetic ketoacidosis 2
  • Higher insulin doses are often required during puberty 2

Practical Considerations for All Patients

Injection Technique

  • Inject subcutaneously into abdomen, thigh, or deltoid areas 1
  • Rotate injection sites within the same region to reduce lipodystrophy risk 1
  • Use short needles (4-mm pen needles) to avoid intramuscular injection 2, 6
  • Never share insulin pens, syringes, or needles between patients 1

Monitoring and Adjustment

  • Increase frequency of blood glucose monitoring when initiating or changing insulin regimens 1
  • Use fasting plasma glucose values to titrate basal insulin 6
  • Use both fasting and postprandial glucose values to titrate mealtime insulin 6
  • Equip patients with an algorithm for self-titration based on self-monitoring of blood glucose 2

Common Pitfalls to Avoid

  • Delaying insulin initiation when clearly indicated by severe hyperglycemia 2, 7
  • Failing to adequately titrate insulin doses to reach glycemic targets 3
  • Not educating patients on proper injection technique, leading to variable absorption 2
  • Abruptly discontinuing oral medications when starting insulin therapy 6
  • Overlooking the importance of consistent timing for basal insulin administration 2

By following these guidelines, insulin therapy can be safely and effectively initiated to improve glycemic control and reduce the risk of diabetes-related complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

An overview of insulin therapy for the non-specialist.

Diabetes, obesity & metabolism, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Research

[Insulin detemir (Levemir)].

Revue medicale de Liege, 2005

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Guideline

Initial Treatment for New Onset Diabetes Mellitus with A1C 7.0%

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.